Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phillips Medisize is a global leader in contract design, development and manufacturing services for the pharmaceutical, medtech and in vitro diagnostics industries. The company specializes in complex drug delivery systems such as auto-injectors and inhalers as well as diagnostic consumables. It partners with most top global pharma/medtech companies to bring innovative medical products from concept through commercial manufacturing. As a Molex company under Koch Industries ownership since its acquisition in 2016–2017, it leverages significant scale and investment to support customers worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phillips Medisize.